1. Home
  2. SLGL vs NMT Comparison

SLGL vs NMT Comparison

Compare SLGL & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

N/A

Current Price

$42.02

Market Cap

117.8M

Sector

Health Care

ML Signal

N/A

Logo Nuveen Massachusetts Quality Municipal Income Fund

NMT

Nuveen Massachusetts Quality Municipal Income Fund

N/A

Current Price

$11.48

Market Cap

107.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SLGL
NMT
Founded
1997
1993
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
117.8M
107.8M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
SLGL
NMT
Price
$42.02
$11.48
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$50.00
N/A
AVG Volume (30 Days)
15.1K
19.1K
Earning Date
11-20-2025
01-01-0001
Dividend Yield
N/A
3.21%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,970,000.00
N/A
Revenue This Year
$121.82
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
62.04
N/A
52 Week Low
$4.02
$9.05
52 Week High
$52.26
$10.93

Technical Indicators

Market Signals
Indicator
SLGL
NMT
Relative Strength Index (RSI) 55.90 42.04
Support Level $39.26 $11.45
Resistance Level $44.04 $11.65
Average True Range (ATR) 3.07 0.08
MACD -0.03 -0.01
Stochastic Oscillator 66.20 15.00

Price Performance

Historical Comparison
SLGL
NMT

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About NMT Nuveen Massachusetts Quality Municipal Income Fund

Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: